Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2141-17-5

Post Buying Request

2141-17-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2141-17-5 Usage

Description

4-Hydroxy-Testosterone is a metabolite of the aromatase inhibitor Formestane (F692250) and is classified as an anabolic steroid. It is a white solid with no therapeutic indication and is considered a controlled substance. The presence of 4-Hydroxy-Testosterone in urine can be utilized as a biomarker for detecting steroid misuse.

Uses

Used in Anti-Doping Applications:
4-Hydroxy-Testosterone is used as a biomarker for steroid misuse, particularly in the field of sports and athletics. Its detection in urine samples helps in identifying the abuse of anabolic steroids, ensuring fair competition and adherence to anti-doping regulations.
Used in Pharmaceutical Research:
4-Hydroxy-Testosterone, being a metabolite of the aromatase inhibitor Formestane, is used in pharmaceutical research for studying the effects and mechanisms of action of such inhibitors. This aids in the development of potential treatments for conditions related to hormonal imbalances or steroid misuse.
Used in Toxicology and Forensic Analysis:
In the fields of toxicology and forensic analysis, 4-Hydroxy-Testosterone is utilized as a marker for anabolic steroid abuse. Its detection in biological samples can provide valuable information in cases involving substance abuse or illicit drug use, assisting in legal proceedings and investigations.

Check Digit Verification of cas no

The CAS Registry Mumber 2141-17-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,4 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2141-17:
(6*2)+(5*1)+(4*4)+(3*1)+(2*1)+(1*7)=45
45 % 10 = 5
So 2141-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C19H28O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,16,21-22H,3-10H2,1-2H3/t11-,12-,13-,16-,18+,19-/m0/s1

2141-17-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Hydroxy Testosterone

1.2 Other means of identification

Product number -
Other names (8R,9S,10R,13S,14S,17S)-4,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2141-17-5 SDS

2141-17-5Relevant articles and documents

Kaufmann

, p. 1348 (1964)

-

Camerino et al.

, p. 3540 (1956)

-

C-19 steroids for cosmetic uses

-

Paragraph 0092, (2016/05/19)

The present invention relates to novel uses of C-19 steroid compounds, in particular C-19 steroids having an androsten-17-(OR 4 )-3-one structure for cosmetic and further uses, wherein R 4 is hydrogen or an unsubstituted or substituted alkyl, aryl, acyl or any group leading to hydroxyl upon biological metabolization or chemical deprotection. The present invention particularly relates to selected C-19 steroids displaying properties of high binding affinity to androgen receptor to block dihydotestosterone from binding, while at the same time providing anabolic effects, which is useful for certain applications, particularly for influencing or controlling problems of the skin and its skin-associated body structures like cellulite, wrinkles, adipose fat tissues, hair follikles or hair growth; for influencing or controlling gland function and activity such as the sebaceous gland and other glands affecting the skin and/or perspiration. The present invention also describes a composition comprising a combination of such a compound and dimethyl isosorbide.

Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers

-

Page/Page column 5-6, (2008/06/13)

The present invention relates to novel uses of 4,17β-dihydroxyandrost-4-ene-3-one (hereinafter 4-hydroxytestosterone), to a process for their preparation, to pharmaceutical compositions containing them, and to the use of said compounds for the prophylaxis and/or treatment of hormone-dependent or hormone receptor regulated cancers in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2141-17-5